Intelligent Bio Solutions Inc.
INBS
$2.47
$0.041.65%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 38.09% | 33.26% | 18.14% | 3.27% | -1.90% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 38.09% | 33.26% | 18.14% | 3.27% | -1.90% |
| Cost of Revenue | 19.90% | 70.64% | 31.26% | 13.70% | 7.09% |
| Gross Profit | 64.41% | 7.07% | 5.82% | -7.90% | -12.54% |
| SG&A Expenses | 17.42% | 15.10% | 14.45% | 9.78% | -3.92% |
| Depreciation & Amortization | -3.64% | -1.35% | -1.77% | 1.41% | 0.55% |
| Other Operating Expenses | 17.03% | -59.64% | -95.35% | -100.48% | -92.30% |
| Total Operating Expenses | 22.08% | 13.46% | 4.26% | 0.52% | 0.70% |
| Operating Income | -17.40% | -7.84% | -0.35% | 0.32% | -1.49% |
| Income Before Tax | -17.57% | -13.17% | -5.60% | -4.32% | -4.06% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -17.57% | -13.17% | -5.60% | -4.32% | -4.06% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 4.43% | 16.43% | 10.63% | 7.76% | 5.87% |
| Net Income | -17.62% | -13.16% | -5.58% | -4.31% | -4.06% |
| EBIT | -17.40% | -7.84% | -0.35% | 0.32% | -1.49% |
| EBITDA | -17.22% | -8.47% | -2.00% | 0.60% | -1.62% |
| EPS Basic | 53.60% | 51.05% | 57.36% | 66.31% | 87.68% |
| Normalized Basic EPS | 54.55% | 53.61% | 59.20% | 67.52% | 87.87% |
| EPS Diluted | 53.60% | 51.08% | 57.38% | 66.32% | 87.68% |
| Normalized Diluted EPS | 54.55% | 53.61% | 59.20% | 67.52% | 87.87% |
| Average Basic Shares Outstanding | 179.43% | 138.92% | 128.88% | 161.63% | 237.08% |
| Average Diluted Shares Outstanding | 179.43% | 138.92% | 128.88% | 161.63% | 237.08% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |